TCL Archive NIH Grant Funding to Use Percentiles Instead Of Priority Scores; Minimal Impact Seen By NCI January 22, 1988
TCL Archive NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent. February 23, 2001
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
